Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Aussie And Kiwi Researchers Make Double MS Genetic Discovery
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.

Study Examines Gender Differences In Immune System's Response To HIV
New research showing that "a receptor molecule involved in the recognition of HIV-1 responds to the virus differently in women than in men," might "explain why HIV infection progresses faster to AIDS in women than in men with similar viral loads," the HealthDay/Greenville Daily Reflector reports. The study was conducted by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University and will be published in an upcoming issue of the journal Nature Medicine. Study authors also note that during the early stages of infection, women tend to have a stronger immune response to HIV than men, but then progress to AIDS more quickly. The different immune system response "then leads to differences in chronic T-cell activation, a known activator of disease progression, according to the researchers," the article states (7/13). Researcher Marcus Altfeld said the findings raise new questions about how sex hormones affect HIV in the body. "Focusing on immune activation separately from viral replication might give us new therapeutic approaches" to treating HIV, he added (AFP/Google News, 7/13).
News of the day
Medicare: A Critical Element Of Health Care Reform
A panel of senior advocates and health policy experts gathered on Capitol Hill
Public Health

New Breast Implant Designed As Alternative To Silicone Gel

At a time when breast augmentation tops the list for U.S. cosmetic surgical procedures, women are still left choosing between either the safety of saline or the natural result of silicone gel. Plastic surgeons are now looking to offer the best features of both in the revolutionary new technology of the IDEAL IMPLANT® Saline-filled Breast Implant. A clinical trial is launching this month in select markets nationwide, giving some women the opportunity to be among the first to have this new implant. The first major new breast implant technology in over 20 years, the IDEAL IMPLANT is designed to offer the natural result of silicone gel, but with only saline inside to give peace of mind. Its novel yet simple design was developed by a noted plastic surgeon expert and consists of a series of implant shells of increasing size nested together. The internal perforated shells control saline movement to reduce "sloshing and bouncing." The IDEAL IMPLANT is also engineered to conform to the chest wall with the edge low, to minimize the unattractive wrinkling on the sides often associated with standard saline implants. Despite recent FDA approval of silicone gel implants, standard saline implants represent about 60 percent of all breast augmentations, reflecting women"s desire for the benefits and safety of saline. The IDEAL IMPLANT looks to provide natural results similar to silicone gel implants, but without the safety concerns, such as difficulty detecting silent ruptures requiring MRI scans, diffusion of small silicone compounds into the tissues, and possible long-term side effects. "With advances in healthcare technology and an awakening of environmental consciousness, Americans are more aware of what we put into our bodies than ever before - we eat organic food, avoid pesticides, and scrutinize labels," explains Dr. Robert S. Hamas, M.D., the plastic surgeon inventor of the IDEAL IMPLANT. "Women seeking breast augmentation are increasingly informed about the potential risks and benefits. I designed the IDEAL IMPLANT to meet the needs of today"s women, who want a natural result but prefer the safety of saline." The selected plastic surgeons in Atlanta, Dallas, Houston, Southeast Florida (Miami and Fort Lauderdale area), and Southern California (Los Angeles and Orange County area), will enroll a total of 500 women in the clinical trial, set to provide the FDA with the data needed to establish the safety and effectiveness of the IDEAL IMPLANT. The trial is open to healthy women who are undergoing a first breast augmentation or the replacement of their existing augmentation implants. Women interested in the IDEAL IMPLANT are encouraged to make a consultation appointment with one of the plastic surgeon investigators to get acquainted and learn about both the benefits and risks of breast augmentation. Ideal Implant Incorporated is offering a unique follow-up incentive plan to patients who complete all required follow-up visits for the trial. For a full list of participating surgeons and contact information, please see the "To Enroll" section of the Web site at http://www.idealimplant.com. Ideal Implant Incorporated


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009